Back to News
Market Impact: 0.18

Trump-Erdoğan ‘bromance’ a ‘great thing,’ Turkey-Israel ties will get better: US ambassador

Geopolitics & WarEmerging MarketsTrade Policy & Supply ChainInfrastructure & DefenseEnergy Markets & PricesLegal & Litigation

US Ambassador to Turkey Tom Barrack framed the close personal tie between Presidents Trump and Erdoğan as central to US policy while describing Turkey as a strategic NATO partner located on key trade and energy routes. He warned Turkey’s economy is “in a bit of a crisis” and said bilateral trade with Israel — a reported ~$7 billion surplus as of Oct. 5th — collapsed almost overnight amid Gaza-related political ruptures, though he expects a return to cooperation once the conflict moves to a political phase. Barrack highlighted Turkey’s mediator role with Hamas and pushed for Turkish participation in a prospective international stabilization force for Gaza, noting such deployments would be complicated by ongoing international legal scrutiny and genocide-related proceedings.

Analysis

Market structure: A sustained Trump–Erdoğan rapprochement materially raises the probability of near‑term capital re‑entry into Turkish assets (equities, sovereign USD bonds, TRY), while bilateral trade with Israel and short‑term goods flows have already collapsed (>$7bn overnight drop in bilateral surplus). Winners: Turkish exporters, defense suppliers (ASELSAN domestically; LMT/RTX internationally on higher regional defense budgets), LNG and shipping owners if Bosporus transit volatility rises. Losers: Israeli‑facing traders, regional insurers, and short‑duration EM debt holders facing FX contagion. Risk assessment: Tail risks include Turkish military escalation or a Bosporus closure (low probability, >$20/bbl shock to Brent) and renewed US sanctions if Ankara pivots toward Russia; these would blow out USD/TRY > +30% moves and Turkish 5y CDS >500bps. Timeline: immediate (days) = FX and CDS spikes around headlines; short (weeks–months) = portfolio reallocations and trade re‑routing; long (quarters–years) = structural policy changes or partial sanctions relief. Catalysts: US admin statements on S‑400/sanctions within 30–90 days, Gaza ceasefire, and any formal Turkey role in Gaza stabilization. Trade implications: Tactical: establish a modest 2–3% long in TUR (iShares MSCI Turkey) with 12‑month target +30–40% and strict 20% stop, paired with a 1–2% short in EEM to isolate Turkey‑specific rerating. Add 1–2% long in LMT or RTX (defense) for 6–18 months to capture higher regional procurement; hedge tail risk with 3‑month GLD calls (0.5–1% portfolio) and a 3‑6 month USD/TRY put spread if available to protect against adverse FX moves. Entry signals: buy on headlines confirming normalization or USD/TRY tightening >10% from local peaks; reduce on CDS widening >100bps. Contrarian angles: Market consensus treats Turkey as persistently toxic; that may be overstated given a pro‑Trump US administration which can deliver sanction relief — a mispricing that could compress Turkish CDS by 100–300bps and revalue TUR materially. Conversely, normalization expectations are underpriced relative to legal/regulatory risks (ICJ, Gaza investigations) that could deter Western investors; therefore size positions small, use pair hedges and option protection, and be ready to flip exposure within 30–90 days as political signals clarify.